- Home
- EQ vs LMFA Comparison
EQ vs LMFA Comparison
Compare EQ & LMFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EQ
- LMFA
- Stock Information
- Founded
- EQ 2017
- LMFA 2008
- Country
- EQ United States
- LMFA United States
- Employees
- EQ N/A
- LMFA N/A
- Industry
- EQ Biotechnology: Pharmaceutical Preparations
- LMFA Finance: Consumer Services
- Sector
- EQ Health Care
- LMFA Finance
- Exchange
- EQ Nasdaq
- LMFA Nasdaq
- Market Cap
- EQ 12.2M
- LMFA 11.9M
- IPO Year
- EQ 2018
- LMFA 2015
- Fundamental
- Price
- EQ $0.41
- LMFA $3.94
- Analyst Decision
- EQ Buy
- LMFA Hold
- Analyst Count
- EQ 3
- LMFA 1
- Target Price
- EQ $3.00
- LMFA N/A
- AVG Volume (30 Days)
- EQ 519.6K
- LMFA 5.1M
- Earning Date
- EQ 08-07-2025
- LMFA 08-13-2025
- Dividend Yield
- EQ N/A
- LMFA N/A
- EPS Growth
- EQ N/A
- LMFA N/A
- EPS
- EQ N/A
- LMFA N/A
- Revenue
- EQ $30,406,000.00
- LMFA $8,029,601.00
- Revenue This Year
- EQ N/A
- LMFA $0.98
- Revenue Next Year
- EQ N/A
- LMFA $4.31
- P/E Ratio
- EQ N/A
- LMFA N/A
- Revenue Growth
- EQ N/A
- LMFA N/A
- 52 Week Low
- EQ $0.27
- LMFA $1.02
- 52 Week High
- EQ $1.50
- LMFA $5.14
- Technical
- Relative Strength Index (RSI)
- EQ 60.48
- LMFA 63.58
- Support Level
- EQ $0.29
- LMFA $2.16
- Resistance Level
- EQ $0.43
- LMFA $5.14
- Average True Range (ATR)
- EQ 0.06
- LMFA 0.56
- MACD
- EQ 0.01
- LMFA 0.21
- Stochastic Oscillator
- EQ 64.21
- LMFA 60.78
About EQ Equillium Inc.
Equillium Inc is a clinical-stage biotechnology company engaged in developing novel therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. The company intends to commercialize its product candidates either independently or through partnerships, or otherwise monetize its pipeline through strategic transactions. Itolizumab (EQ001), a clinical-stage product candidate, is an anti-CD6 immune-modifying monoclonal antibody, or mAb, that selectively targets the CD6-ALCAM signaling pathway to downregulate pathogenic T effector cells while preserving T regulatory cells critical for maintaining a balanced immune response. The company's other clinical-stage and pre-clinical-stage candidates include EQ101 and EQ302.
About LMFA LM Funding America Inc.
LM Funding America Inc is a financial services company. The company provides funding to nonprofit community associations located in the state of Florida and to nonprofit community associations in the states of Washington and Colorado. Its products include Original Product and New Neighbor Guaranty. Its original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. It currently has two lines of business recently commenced cryptocurrency mining business and historical specialty finance business. The Company has two operating segments: Specialty Finance and Mining Operations, which generate the majority of its revenue.